Credit Suisse Ag Arvinas, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Arvinas, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 262,224 shares of ARVN stock, worth $4.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

262,224

Previous 142,108 84.52%

Holding current value

$4.53 Million

Previous $5.85 Million 85.06%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$36.38 - $52.31 $4.37 Million - $6.28 Million	120,116 Added 84.52%	262,224 $10.8 Million
Q4 2023 Feb 08, 2024	BUY	$14.19 - $42.33 $1.23 Million - $3.68 Million	86,845 Added 157.15%	142,108 $5.85 Million
Q3 2023 Nov 13, 2023	SELL	$19.64 - $28.21 $7,757 - $11,142	-395 Reduced 0.71%	55,263 $1.09 Million
Q2 2023 Aug 11, 2023	BUY	$21.73 - $31.43 $71,296 - $103,121	3,281 Added 6.26%	55,658 $1.38 Million
Q1 2023 May 10, 2023	BUY	$26.15 - $37.26 $83,183 - $118,524	3,181 Added 6.47%	52,377 $1.43 Million
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $354,767 - $625,404	10,926 Added 28.55%	49,196 $1.68 Million
Q3 2022 Nov 10, 2022	BUY	$41.87 - $57.99 $87,592 - $121,315	2,092 Added 5.78%	38,270 $1.7 Million
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $66,258 - $136,601	1,840 Added 5.36%	36,178 $1.52 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $345,949 - $468,211	5,740 Added 20.07%	34,338 $2.31 Million
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $150,796 - $220,320	-2,290 Reduced 7.41%	28,598 $2.35 Million
Q3 2021 Nov 12, 2021	BUY	$73.2 - $107.87 $14,127 - $20,818	193 Added 0.63%	30,888 $2.54 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $348,736 - $486,095	5,769 Added 23.14%	30,695 $2.36 Million
Q1 2021 May 14, 2021	SELL	$58.19 - $91.37 $517,600 - $812,736	-8,895 Reduced 26.3%	24,926 $1.65 Million
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $343,573 - $1.45 Million	17,017 Added 101.27%	33,821 $2.87 Million
Q3 2020 Nov 13, 2020	SELL	$22.99 - $36.34 $29,450 - $46,551	-1,281 Reduced 7.08%	16,804 $395,000
Q2 2020 Aug 12, 2020	BUY	$29.88 - $56.74 $205,813 - $390,825	6,888 Added 61.52%	18,085 $606,000
Q1 2020 May 13, 2020	SELL	$33.0 - $54.5 $508,332 - $839,518	-15,404 Reduced 57.91%	11,197 $451,000
Q4 2019 Feb 12, 2020	BUY	$15.39 - $44.38 $210,273 - $606,363	13,663 Added 105.6%	26,601 $1.09 Million
Q3 2019 Nov 12, 2019	BUY	$21.55 - $27.61 $278,813 - $357,218	12,938 New	12,938 $278,000

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

70.9M

Call Options Held

1.52M

Put Options Held

346K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $918M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account